UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current
Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 18, 2023
Bannix Acquisition Corp.
(Exact Name of Registrant as Specified in its Charter)
Delaware | 1-40790 | 86-1626016 | ||
(State
or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S.
Employer Identification No.) |
8265
West Sunset Blvd., Suite # 107 West Hollywood, CA |
90046 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (323) 682-8949
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01. Entry into a Material Definitive Agreement
On April 17, 2023, Bannix Acquisition Corp. (“Bannix”), EVIE Autonomous Group Ltd. (“EVIE”) and EVIE’s shareholders entered into a Business Combination Agreement pursuant to which Bannix agreed to acquire EVIE. In addition, on August 8, 2023, Bannix entered into a Patent Purchase Agreement (“PPA”) with GBT Tokenize Corp. (“Tokenize”), which is 50% owned by GBT Technologies Inc. (“GBT”), where GBT provided its consent, to acquire the entire right, title, and interest to intellectual property including patents and patent applications providing a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and moving objects. The closing date of the PPA will be immediately following the closing of the acquisition of EVIE by Bannix. The Purchase Price is set at 5% of the consideration that Bannix is paying to the shareholders of EVIE. The Business Combination Agreement sets the consideration to be paid by Bannix at $850 million and, in turn, the consideration in the PPA to be paid to Tokenize is $42.5 million. If the final purchase price is less than $30 million, Tokenize has the option to cancel the PPA. In accordance therewith, Bannix agrees to pay, issue and deliver to Tokenize, $42.5 million in Series A Preferred Stock to Tokenize, which such terms will be more fully set forth in the Series A Preferred Stock Certificate of Designation to be filed with the Secretary of State of the State of prior to the closing date. The Series A Preferred Stock will have stated value of face value of $1,000 per share and is convertible, at the option of Tokenize, into shares of common stock of Bannix at 5% discount to the VWAP during the 20 trading days prior to conversion, and in any event not less than $1.00. The Series A Preferred Stock will not have voting rights and will be entitled to dividends only in the event of liquidation. The Series A Preferred Stock will have a 4.99% beneficial ownership limitation.
Series A Preferred Stock and the shares of common stock issuable upon conversion of the Series A Preferred Stock (the “Conversion Shares”) shall be subject to a lock-up beginning on the closing date and ending on the earliest of (i) the six (6) months after such date, (ii) a change in control, or (iii) written consent of Bannix (the “Seller Lockup Period”)
On December 18, 2023, Bannix and Tokenize entered into Amendment No. 1 to the PPA. Per the amendment, Bannix and Tokenize agreed that the shares of common stock to be issued upon conversion of the Series A Preferred Stock will not exceed 19.99% of the aggregate number of shares of common stock issued and outstanding as of the closing of Bannix’s acquisition of EVIE (such maximum number of shares, the “Exchange Cap”) unless Bannix’s stockholders have approved the issuance of shares of common stock upon conversion of the Series A Preferred Stock pursuant to the PPA in excess of the Exchange Cap in accordance with the applicable rules of the market or exchange on which Bannix’s shares of common stock trade.
The foregoing description of the terms of the above transactions do not purport to be complete and are qualified in their entirety by reference to the provisions of such agreements, the forms of which are filed as exhibits to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits. The following exhibits are filed with this Form 8-K:
Exhibit Number | Description |
10.1 | Amendment No. 1 to Patent Purchase Agreement dated August 8, 2023 between GBT Tokenize Corp. and Bannix Acquisition Corp. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: December 19, 2023 | ||
BANNIX ACQUISITION CORP. | ||
By: | /s/ Douglas Davis | |
Name: | Douglas Davis | |
Title: | Chief Executive Officer |
EXHIBIT 10.1
AMENDMENT NO. 1 TO PATENT PURCHASE AGREEMENT
This Amendment No. 1 to the Patent Purchase Agreement (the "Amendment") dated December 18, 2023 is entered into by and between Bannix Acquisition Corp. (the “Purchaser”) and GBT Tokenize Corp. (the "Seller").
WHEREAS, the Purchaser and the Seller are parties to that certain Patent Purchase Agreement, dated August 8, 2023 (the "Patent Purchase Agreement"), pursuant to which, among other things, the Purchaser agreed, on the Closing Date, to acquire the Patents from the Seller on the terms and subject to the conditions set forth in the Patent Purchase Agreement;
WHEREAS, capitalized terms used in this Amendment, but not otherwise defined herein, are used herein with the respective meanings ascribed to such terms under the Patent Purchase Agreement;
WHEREAS, Purchaser and Seller wish to amend the Patent Purchase Agreement as set forth herein.
NOW, THEREFORE, in consideration of the foregoing, and the mutual terms, covenants and conditions herein below set forth, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:
1. Amendments to the Patent Purchase Agreement. Purchaser and Seller agree to add Section 2.4 to the Patent Purchase Agreement as follows:
Notwithstanding anything to the contrary herein, the Seller may not convert the Series A Preferred Stock into shares of common stock of the Purchaser to the extent that after giving effect to conversion the aggregate number of shares of common stock issued under the Agreement would exceed 19.99% of the aggregate number of shares of common stock issued and outstanding as of the closing of the Purchaser’s acquisition of EVIE Autonomous Group Ltd. (such maximum number of shares, the “Exchange Cap”) unless the Company’s stockholders have approved the issuance of shares of common stock upon conversion of the Series A Preferred Stock pursuant to this Agreement in excess of the Exchange Cap in accordance with the applicable rules of the market or exchange on which the Purchaser’s shares of common stock trade.
2. Miscellaneous. This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Amendment delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy.
IN WITNESS WHEREOF, the parties have executed this Agreement the day and year first above written.
GBT TOKENIZE CORP.
By:___________________________
Name: Michael Murray
Title: CEO
BANNIX ACQUISITION CORP.
By:___________________________
Name: Douglas Davis
Title: CEO
We give our consent:
GBT Technologies, Inc.
By:___________________________
Name: Mansour Khatib
Title: Chief Executive Officer